Molecular structure, conformational stability, energetic and intramolecular hydrogen bonding in ground, and electronic excited state of 3-mercapto propeneselenal

被引:0
作者
Maryam Shokhmkar
Heidar Raissi
Fariba Mollania
机构
[1] University of Birjand,Computational Chemistry Lab, Department of Chemistry
来源
Structural Chemistry | 2014年 / 25卷
关键词
3-Mercapto propeneselenal; Molecular structure; Ab-initio and DFT calculation; Intramolecular hydrogen bond; TD-DFT;
D O I
暂无
中图分类号
学科分类号
摘要
In the present work, a conformational analysis of 3-mercapto propeneselenal is performed using several computational methods, including DFT (B3LYP), MP2, and G2MP2. At the DFT and G2MP2 levels the most stable conformers of title compound are characterized by an extended backbone structure, minimizing the steric repulsions between the sulfur and selenium lone pairs. Two conformers exhibit hydrogen bonding. This feature, although not being the dominant factor in energetic terms, appears to be of foremost importance to define the geometry of the molecule. The influence of the solvent on the stability order of conformers and the strength of intramolecular hydrogen bonding was considered using the PCM, SCI–PCM, and IEF–PCM methods. The results of analysis by quantum theory of “Atoms in Molecules” and natural bond orbital method fairly support the DFT results. The calculated HOMO and LUMO energies showed that charge transfer occurs within the molecule. Further verification of the obtained transition state structures was implemented via intrinsic reaction coordinate analysis. Calculations of the 1H NMR chemical shift at GIAO/B3LYP/6–311++G** levels of theory are also presented. The excited-state properties of intramolecular hydrogen bonding in hydrogen-bonded systems have been investigated theoretically using the time-dependent density functional theory method.
引用
收藏
页码:1153 / 1164
页数:11
相关论文
共 159 条
[1]  
Srivastava PC(1983)undefined J Med Chem 26 445-448
[2]  
Robins RK(1999)undefined Anticancer Res 19 5375-5382
[3]  
Wu W(2002)undefined Exp Opin Invest Drugs 11 1261-1269
[4]  
Murakami K(1991)undefined Prog Drug Res 36 9-47
[5]  
Koketsu M(1998)undefined Res Commun Mol Pathol Pharmacol 101 179-186
[6]  
Yamada Y(1997)undefined J Pharm Exp Ther 283 470-477
[7]  
Saiki I(2004)undefined J Sulfur Chem 25 39-62
[8]  
May SW(2011)undefined Br J Pharm Res 1 46-65
[9]  
Parnham MJ(2012)undefined Int J Quant Chem 112 2378-2381
[10]  
Graf E(1997)undefined J Phys Chem A 101 9710-9719